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We  read with interest the review article by Saito et al. on the
ssociation between granzyme B and cardiovascular disease (CVD)
1] along with their original papers [2,3]. Their review mainly
ocuses on the role of apoptosis in CVD via granzyme B/perforin
ystem, and patients with established CVD such as acute coronary
yndrome [2],  coronary artery disease with end-stage renal disease
3],  and sub-acute stage of myocardial infarction. Peripheral blood
ononuclear cells (MNC), culture supernatant of MNC, and plasma
ranzyme B were used for the analysis. As a conclusion, granzyme
 is a novel indicator for CVD especially relating to the acute and
hronic inﬂammation in CVD. They also recommended the possi-
ility of a therapeutic approach for CVD by making inhibitors of
ranzyme B, although there is a lack of information on this area.
e think that their review is valid and summarizes the association
etween granzyme B/perforin system and CVD, which is informa-
ive in parallel with oxidative stress markers on CVD [4].
We previously conducted research to explore the association
etween lifestyles and granzymes-expressing natural killer (NK)
ells in the peripheral blood of 114 healthy male subjects [5].
s a conclusion, subjects with poor lifestyle showed a signiﬁcant
ecrease in granzyme B-expressing NK cells, whereas no change
as observed in CD3-positive cells with granzyme B production.
hese results indicated that poor lifestyle caused a decrease in
ranzyme B-positive NK cells but it did not affect granzyme B-
roducing T-cells.
Although we did not study CVD patients and were interested
n lymphocyte populations, these researches were different from
ach other, and the opposite direction in change of granzyme B
as observed. It can be considered that the higher expression of
914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.04.002granzyme B by NK cells becomes beneﬁcial for tumor prevention
and that lower granzyme B production by T-cells prevents onset
of CVD. Plasma granzyme B might originate from T-cells and its
concentration can be used as an alternative biomarker for granzyme
B production by T-cells.
It would be of interest to know if granzyme B retains its predic-
tive ability for subjects with several metabolic risk factors.
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